Category Archives: Policy News
Utah Healthcare Innovation Network (UHIN) Announces Inaugural Cohort of Healthcare Startups
Utah Healthcare Innovation Network (UHIN) Announces Inaugural Cohort of Healthcare Startups
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025. A strategic, results-oriented leader with more than 20 years of experience in healthcare, diagnostics, and medical […]
BioUtah Award Winners and Utah Rare Disease Advisory Council Take Center Stage at Utah Life Sciences Innovation Caucus
More than a dozen Utah legislators on Wednesday, November 20, held a breakfast meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol.
BioUtah and Coalition of Patient Advocates Talk PBM Reform with U.S. Reps. Blake Moore and Celeste Maloy
BioUtah’s VP for Government Affairs, Denise Bell, along with a coalition of patient advocates, life sciences executives, pharmacists, physicians, oncologists, and community organizations, held a lunch meeting with Representatives Blake Moore (R-UT) and Celeste Maloy (R-UT) October 1 to discuss the dangers of giving pharmacy benefit managers (PBMs) command over how much patients pay for […]
UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX
Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.
bioMeriéux, Curza, Present to Utah Life Sciences Innovation Caucus
Utah legislators on Wednesday, August 21, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol. BioUtah President and CEO, Kelvyn Cullimore, introduced representatives from Salt Lake City-based bioMeriéux and Curza who presented before the ULSIC. Megan Kuehn, senior vice president of site operations for bioMeriéuxi, described the company’s development […]
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
Ingenion Medical Obtains CE Mark for Catheter
The cymactive catheter is the first in a pipeline of urology solutions the UK-based company has planned.
Anbex Awarded Bid from Hong Kong’s Department of Health
Anbex Awarded Bid from Hong Kong’s Department of Health
Final Amendments to Strengthen Air Toxics Standards for Ethylene Oxide Commercial Sterilizers
Final Amendments to Strengthen Air Toxics Standards for Ethylene Oxide Commercial Sterilizers
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics
Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the completion […]
Seek Labs Unveils SeekIt™
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient.
